Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-10

Clinical Trial Update: Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether transdermal nicotine replacement therapy (nicotine patch) induces metabolic changes in smokers; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine transdermal patch (nicotine patch)

Snippet

Sponsor: The Queen Elizabeth Hospital | Conditions: Smoking, Addiction | Phase 1 | Status: COMPLETED